Recommended Antibiotic Dosing for Uncomplicated Urinary Tract Infections (UTIs)
For uncomplicated bacterial cystitis in women, prescribe nitrofurantoin for 5 days, trimethoprim-sulfamethoxazole (TMP-SMX) for 3 days, or fosfomycin as a single dose. For uncomplicated pyelonephritis, prescribe fluoroquinolones for 5-7 days or TMP-SMX for 14 days based on antibiotic susceptibility. 1
First-Line Treatment Options for Uncomplicated Cystitis
Women with Uncomplicated Cystitis
- Nitrofurantoin: 100 mg orally twice daily for 5 days 1
- TMP-SMX: One double-strength tablet (160/800 mg) orally twice daily for 3 days 1, 2
- Fosfomycin: 3 g single oral dose 1
Important Considerations
- Escherichia coli accounts for >75% of all bacterial cystitis cases, so empirical antibiotics should target this organism 1
- Fluoroquinolones should not be used as first-line empiric therapy despite high efficacy in 3-day regimens due to:
Treatment for Uncomplicated Pyelonephritis
Oral Therapy Options
- Fluoroquinolones:
- TMP-SMX: One double-strength tablet (160/800 mg) twice daily for 14 days (when susceptibility is known) 1, 2
Parenteral Therapy Options (if hospitalization required)
- Ciprofloxacin: 400 mg IV twice daily 1
- Levofloxacin: 750 mg IV once daily 1
- Ceftriaxone: 1-2 g IV once daily 1
- Gentamicin: 5 mg/kg IV once daily 1
Special Considerations
Antibiotic Resistance
- Local resistance patterns should guide empiric therapy choices 1, 3
- TMP-SMX should not be used empirically for pyelonephritis without culture and susceptibility testing due to high resistance rates 1
- Recent studies show 5-day courses of fluoroquinolones are noninferior to 10-day courses for pyelonephritis, with clinical cure rates >93% 1
Catheter-Associated UTIs
- For catheter-associated UTIs with prompt symptom resolution: 7-day treatment course 1
- For catheter-associated UTIs with delayed response: 10-14 day treatment course 1
- Levofloxacin 750 mg daily for 5 days may be considered for non-severe catheter-associated UTIs 1
- A 3-day regimen may be appropriate for women ≥65 years who develop catheter-associated UTI without upper tract symptoms after catheter removal 1
Multidrug-Resistant Organisms
- For uncomplicated UTIs due to vancomycin-resistant enterococci (VRE):
- For simple cystitis due to carbapenem-resistant Enterobacteriaceae (CRE):
- Single-dose aminoglycoside therapy 1
Common Pitfalls to Avoid
- Treating asymptomatic bacteriuria - this should be avoided as it contributes to antibiotic resistance without clinical benefit 1
- Using fluoroquinolones as first-line empiric therapy for uncomplicated cystitis despite their efficacy due to adverse effects and resistance concerns 1, 3
- Prescribing longer antibiotic courses than necessary, which increases risk of adverse effects without improving outcomes 1, 4
- Failure to adjust therapy based on culture results and clinical response 1
- Not considering local resistance patterns when selecting empiric therapy 1, 3
Treatment Duration Summary
- Uncomplicated cystitis in women:
- Uncomplicated pyelonephritis:
- Catheter-associated UTI: